Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31325732

Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leuk Res
Publication date
2019 Sep
First author
Ganesan P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Ganesan P
      type
      Author
    2. name
      Mehra N
      type
      Author
    3. name
      Joel A
      type
      Author
    4. name
      Radhakrishnan V
      type
      Author
    5. name
      Dhanushkodi M
      type
      Author
    6. name
      Perumal Kalayarasi J
      type
      Author
    7. name
      Kannan K
      type
      Author
    8. name
      Ganesan TS
      type
      Author
    9. name
      Sagar TG
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Ganesan P
      type
      Author
    2. name
      Mehra N
      type
      Author
    3. name
      Joel A
      type
      Author
    4. name
      Radhakrishnan V
      type
      Author
    5. name
      Dhanushkodi M
      type
      Author
    6. name
      Perumal Kalayarasi J
      type
      Author
    7. name
      Kannan K
      type
      Author
    8. name
      Ganesan TS
      type
      Author
    9. name
      Sagar TG
      type
      Author
    bibliography ids
    1. nci-bib-661634b1754609f0b7d08ea1
    book metadata
    content sha256
    44815aa3d1b673bbe7b7369880d6c6f2a356be302a78d66e3c68c28bcf8ff57f
    document type
    citation
    dois
    1. 10.1016/j.leukres.2019.106188
    electronic publication date
    display
    2019 Jul 11
    precision
    day
    year
    2019
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:31325732
    immutable id
    pubmed:31325732@44815aa3d1b673bbe7b7369880d6c6f2a356be302a78d66e3c68c28bcf8ff57f
    journal
    abbreviation
    Leuk Res
    issn electronic
    1873-5835
    issn print
    0145-2126
    issue
    Source null
    name
    Leukemia research
    nlm unique id
    7706787
    pages
    106188
    volume
    84
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      31325732
      provenance
      batch id
      23ffe1e2a9e160b6dca0
      provider
      NCBI PubMed ESummary
      record sha256
      cf2ecee312cc48653fed6fc6b801fa70b78a70b9a87a610fe128c25095689386
      response sha256
      d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
      retrieved at
      2026-09-09T23:47:44.690737+00:00
      publication date
      display
      2019 Sep
      precision
      month
      year
      2019
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/31325732/
      title
      Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma.

      Preserved source evidence · Not medical advice